Anti-inflammatory effect of rosmarinic acid and an extract of rosmarinus officinalis in rat models of local and systemic inflammation

Basic and Clinical Pharmacology and Toxicology

Volumn 116, Issue 5, 2015, Pages 398-413

  Rocha, Joao ^a   Eduardo Figueira, Maria ^a   Barateiro, Andreia ^a   Fernandes, Adelaide ^a   Brites, Dora ^a   Bronze, Rosario ^b   Duarte, Catarina Mm ^b   Serra, Ana Teresa ^b   Pinto, Rui ^a   Freitas, Marisa ^c   Fernandes, Eduarda ^c   Silva Lima, Beatriz ^a   Mota Filipe, Helder ^a   Sepodes, Bruno ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; POLYPHENOL DERIVATIVE; ROSMARINIC ACID; ROSMARINUS OFFICINALIS EXTRACT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; AUTACOID; BIOLOGICAL MARKER; CARRAGEENAN; CINNAMIC ACID DERIVATIVE; DEPSIDE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INFLAMMATION; LIQUID CHROMATOGRAPHY; LIVER INJURY; LIVER ISCHEMIA; LIVER ISCHEMIA REPERFUSION INJURY; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; ROSEMARY; THERMAL INJURY; ANIMAL; BLOOD; BRONCHOALVEOLAR LAVAGE FLUID; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; EDEMA; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG; MEDICINAL PLANT; METABOLISM; NEUTROPHIL; OXIDATIVE STRESS; PHYTOTHERAPY; REPERFUSION INJURY; RESPIRATORY BURST; ROSMARINUS; TIME; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS; ROSMARINUS OFFICINALIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BIOMARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CARRAGEENAN; CINNAMATES; DEPSIDES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; INFLAMMATION; INFLAMMATION MEDIATORS; LUNG; MALE; NEUTROPHILS; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS, WISTAR; REPERFUSION INJURY; RESPIRATORY BURST; ROSMARINUS; TIME FACTORS;

EID: 84926358222     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12335     Document Type: Article

References (75)

1. González-Trujano ME, Peña EI, Martínez AL, Moreno J, Guevara-Fefer P, Déciga-Campos M et al. Evaluation of the antinociceptive effect of Rosmarinus officinalis L. using three different experimental models in rodents. J Ethnopharmacol 2007;111:476-82.
2. Takaki I, Bersani-Amado LE, Vendruscolo A, Sartoretto SM, Diniz SP, Bersani-Amado CA et al. Anti-inflammatory and antinociceptive effects of Rosmarinus officinalis L. essential oil in experimental animal models. J Med Food 2008;11:741-6.
3. del Baño MJ, Lorente J, Castillo J, Benavente-García O, del Río JA, Ortuño A et al. Phenolic diterpenes, flavones, and rosmarinic acid distribution during the development of leaves, flowers, stems, and roots of Rosmarinus officinalis. Antioxidant activity. J Agric Food Chem 2003;51:4247-53.
4. Nakazawa T, Ohsawa K. Metabolism of rosmarinic acid in rats. J Nat Prod 1998;61:993-6.
5. Baba S, Osakabe N, Natsume M, Terao J. Orally administered rosmarinic acid is present as the conjugated and/or methylated forms in plasma, and is degraded and metabolized to conjugated forms of caffeic acid, ferulic acid and m-coumaric acid. Life Sci 2004;75:165-78.
6. Konishi Y, Kobayashi S. Transepithelial transport of rosmarinic acid in intestinal Caco-2 cell monolayers. Biosci Biotechnol Biochem 2005;69:583-91.
7. Debersac P, Vernevaut MF, Amiot MJ, Suschetet M, Siess MH. Effects of a water-soluble extract of rosemary and its purified component rosmarinic acid on xenobiotic-metabolizing enzymes in rat liver. Food Chem Toxicol 2001;39:109-17.
8. Conner EM, Grisham MB. Inflammation, free radicals, and antioxidants. Nutrition 1996;4:274-7.
9. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001;53:135-59.
10. Choi HR, Choi JS, Han YN, Bae SJ, Chung HY. Peroxynitrite scavenging activity of herb extracts. Phytother Res 2002;4:364-7.
11. Nakamura Y, Ohto Y, Murakami A, Ohigashi H. Superoxide scavenging activity of rosmarinic acid from Perilla frutescens Britton Var. acuta f. viridis. J Agric Food Chem 1998;46:4545-50.
12. Peng CH, Su JD, Chyau CC, Sung TY, Ho SS, Peng CC et al. Supercritical fluid extracts of rosemary leaves exhibit potent anti-inflammation and anti-tumor effects. Biosci Biotechnol Biochem 2007;71:2223-32.
13. Qiao S, Li W, Tsubouchi R, Haneda M, Murakami K, Takeuchi F et al. Rosmarinic acid inhibits the formation of reactive oxygen and nitrogen species in RAW264.7 macrophages. Free Radic Res 2005;39:995-1003.
14. Jaeschke H. Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol 2006;6:G1083-8.
15. Jaeschke H, Woolbright BL. Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species. Transplant Rev (Orlando) 2012;2:103-14.
16. Sepodes B, Maio R, Pinto R, Marques C, Mendes-do-Vale J, McDonald MC et al. Tempol, an intracelullar free radical scavenger, reduces liver injury in hepatic ischemia-reperfusion in the rat. Transplant Proc 2004;36:849-53.
17. Ward PA. Oxidative stress: acute and progressive lung injury. Ann N Y Acad Sci 2010;1203:53-9.
18. Zimmerman JJ. Oxidant stress in acute lung injury. In: Wong HR, Shanley T (eds). Molecular Biology of Acute Lung Injury, 1st edn. Springer, Berlin, Germany, 2001;83-99.
19. Crimi E, Sica V, Slutsky AS, Zhang H, Williams-Ignarro S, Ignarro LJ et al. Role of oxidative stress in experimental sepsis and multisystem organ dysfunction. Free Radic Res 2006;40:665-72.
20. Bowler RP, Crapo JD. Oxidative stress in allergic respiratory diseases. J Allergy Clin Immunol 2002;110:349-56.
21. Crapo JD. Oxidative stress as an initiator of cytokine release and cell damage. Eur Respir J 2003;44:4s-6s.
22. Rahman I, Kelly F. Biomarkers in breath condensate: a promising new non-invasive technique in free radical research. Free Radic Res 2003;37:1253-66.
23. Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic 1965;16:144-58.
24. Serra AT, Rocha J, Sepodes B, Matias AA, Feliciano RP, de Carvalho A et al. Evaluation of cardiovascular protective effect of different apple varieties - Correlation of response with composition. Food Chem 2012;135:2378-86.
25. Ou B, Hampsch-Woodill M, Flanagan J, Deemer EK, Prior RL, Huang D. Novel fluorometric assay for hydroxyl radical prevention capacity using fluorescein as the probe. J Agric Food Chem 2002;50:2772-7.
26. Freitas M, Porto G, Lima JL, Fernandes E. Isolation and activation of human neutrophils in vitro: the importance of the anticoagulant used during blood collection. Clin Biochem 2008;41:570-5.
27. Freitas M, Porto G, Lima JL, Fernandes E. Optimization of experimental settings for the analysis of human neutrophils oxidative burst in vitro. Talanta 2009;78:1476-83.
28. Freitas M, Lima JL, Fernandes E. Optical probes for detection and quantification of neutrophils' oxidative burst: a review. Anal Chim Acta 2009;649:8-23.
29. Fernandes E, Costa D, Marques AP, Reis RL, Lima JLFC. Inhibition of human neutrophil oxidative burst by pyrazolone derivatives. Free Radic Biol Med 2006;40:632-40.
30. Vogel HG. Drug Discovery and Evaluation: Pharmacological Assays. Springer-Verlag and Heidelberg GmbH & Co., Berlin, Germany, 2002;751-72.
31. Bignotto L, Rocha J, Sepodes B, Eduardo-Figueira M, Pinto R, Chaud M et al. Anti-inflammatory effect of lycopene on carrageenan-induced paw oedema and hepatic ischaemia-reperfusion in the rat. Br J Nutr 2009;102:126-33.
32. Sepodes B, Maio R, Pinto R, Sharples E, Oliveira P, McDonald M et al. Recombinant human erythropoietin protects the liver from hepatic ischemia-reperfusion injury in the rat. Transpl Int 2006;19:919-26.
33. Fischer AE, Jacobson KA, Rose J, Zeller R. Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc 2008;2008:pdb.prot4986.
34. Schreiber E, Matthias P, Müller MM, Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989;17:6419.
35. Fernandes A, Falcão AS, Silva RF, Gordo AC, Gama MJ, Brito MA et al. Inflammatory signalling pathways involved in astroglial activation by unconjugated bilirubin. J Neurochem 2008;96:1667-79.
36. Barateiro A, Vaz AR, Silva SL, Fernandes A, Brites D. ER stress, mitochondrial dysfunction and calpain/JNK activation are involved in oligodendrocyte precursor cell death by unconjugated bilirubin. Neuromolecular Med 2012;14:285-302.
37. Silva SL, Vaz AR, Barateiro A, Falcão AS, Fernandes A, Brito MA et al. Features of bilirubin-induced reactive microglia: from phagocytosis to inflammation. Neurobiol Dis 2010;40:663-75.
38. Di Rosa M, Giroud JP, Willoughby DA. Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol 1971;104:15-29.
39. Khattab MM. Tempol, a membrane-permeable radical scavenger, attenuates peroxynitrite- and superoxide anion-enhanced carrageenan-induced paw edema and hyperalgesia: a key role for superoxide anion. Eur J Pharmacol 2006;548:167-73.
40. Cuzzocrea S, Zingarelli B, Hake P, Salzman AL, Szabó C. Antiinflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Radic Biol Med 1998;24:450-9.
41. Landino LM, Crews BC, Timmons MD, Morrow JD, Marnett LJ. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci USA 1996;93:15069-74.
42. D'Acquisto F, May MJ, Ghosh S. Inhibition of nuclear factor kappa B (NF-B): an emerging theme in anti-Inflammatory therapies. Mol Interv 2002;2:22-35.
43. Thiemermann C, McDonald MC, Cuzzocrea S. The stable nitroxide, tempol, attenuates the effects of peroxynitrite and oxygen-derived free radicals. Crit Care Med 2001;29:223-4.
44. Cuzzocrea S, Thiemermann C, Salvemini D. Potential therapeutic effect of antioxidant therapy in shock and inflammation. Curr Med Chem 2004;11:1147-62.
45. Naito Y, Takano H, Yoshikawa T. Oxidative stress-related molecules as a therapeutic target for inflammatory and allergic diseases. Curr Drug Targets Inflamm Allergy 2005;4:511-5.
46. Kaplan M, Mutlu EA, Benson M, Fields JZ, Banan A, Keshavarzian A. Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders. Complement Ther Med 2007;15:207-16.
47. Moreno S, Scheyer T, Romano CS, Vojnov AA. Antioxidant and antimicrobial activities of rosemary extracts linked to their polyphenol composition. Free Radic Res 2006;40:223-31.
48. Erkan N, Ayranci G, Ayranci E. Antioxidant activities of rosemary (Rosmarinus officinalis L.) extract, blackseed (Nigella sativa L.) essential oil, carnosic acid, rosmarinic acid and sesamol. Food Chem 2008;110:76-82.
49. Elias-Miró M, Jiménez-Castro MB, Rodés J, Peralta C. Current knowledge on oxidative stress in hepatic ischemia/reperfusion. Free Radic Res 2013;8:555-68.
50. Osakabe N, Yasuda A, Natsume M, Sanbongi C, Kato Y, Osawa T et al. Rosmarinic acid, a major polyphenolic component of Perilla frutescens, reduces lipopolysaccharide (LPS)-induced liver injury in D-galactosamine (D-GalN)-sensitized mice. Free Radic Biol Med 2002;33:798-806.
51. Dahiya P. Burns as a model of SIRS. Front Biosci (Landmark Ed) 2009;1:4962-7.
52. Dancey DR, Hayes J, Gomez M, Schouten D, Fish J, Peters W et al. ARDS in patients with thermal injury. Intensive Care Med 1999;25:1231-6.
53. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003;348:683-93.
54. Rodriguez JL, Miller CG, Garner WL, Till GO, Guerrero P, Moore NP et al. Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J Trauma 1993;34:684-95.
55. Ipaktchi K, Mattar A, Niederbichler AD, Hoesel LM, Vollmannshauser S, Hemmila MR et al. Attenuating burn wound inflammatory signaling reduces systemic inflammation and acute lung injury. J Immunol 2006;177:8065-71.
56. Abdullahi A, Amini-Nik S, Jeschke MG. Animal models in burn research. Cell Mol Life Sci 2014;71(17):3241-55 (in press).
57. Brachkova MI, Marques P, Rocha J, Sepodes B, Duarte MA, Pinto JF. Alginate films containing Lactobacillus plantarum as wound dressing for prevention of burn infection. J Hosp Infect 2011;79:375-7.
58. Jeschke MG, Einspanier R, Klein D, Jauch KW. Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med 2002;8:443-50.
59. Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 2011;44:725-38.
60. Datta G, Fuller BJ, Davidson BR. Molecular mechanisms of liver ischemia reperfusion injury: insights from transgenic knockout models. World J Gastroenterol 2013;11:1683-98.
61. Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med 2011;17:293-307.
62. Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care 2001;7:1-7.
63. Edens HA, Parkos CA. Neutrophil transendothelial migration and alteration in vascular permeability: focus on neutrophil-derived azurocidin. Curr Opin Hematol 2003;10:25-30.
64. Fry DE. Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues. Am Surg 2012;78:1-8.
65. Parks WC, Wilson CL, López-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004;4:617-29.
66. Davey A, McAuley DF, O'Kane CM. Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair. Eur Respir J 2011;38:959-70.
67. Qiu Z, Hu J, Van den Steen PE, Opdenakker G. Targeting matrix metalloproteinases in acute inflammatory shock syndromes. Comb Chem High Throughput Screen 2012;15:555-70.
68. Vandenbroucke RE, Dejonckheere E, Libert C. A therapeutic role for matrix metalloproteinase inhibitors in lung diseases? Eur Respir J 2011;38:1200-14.
69. Baud V, Karin M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 2012;8:33-40.
70. Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 2008;8:837-48.
71. Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-κB signaling pathways. Nat Immunol 2011;12:695-708.
72. Minghetti L. Role of inflammation in neurodegenerative diseases. Curr Opin Neurol 2005;18:315-21.
73. Lin CP, Lin FY, Huang PH, Chen YL, Chen WC, Chen HY et al. Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation. Biomed Res Int 2013;2013:845037.
74. Rosanna DP, Salvatore C. Reactive oxygen species, inflammation, and lung diseases. Curr Pharm Des 2012;18:3889-900.
75. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010;49:1603-16.